Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Combined Blockade of TIGIT and PD-L1 Enhances Anti-Neuroblastoma Efficacy of GD2-Directed Immunotherapy with Dinutuximab Beta.
Cancers (Basel). 2023 Jun 23;15(13):3317. doi: 10.3390/cancers15133317.
Cancers (Basel). 2023.
PMID: 37444427
Free PMC article.
The Immunocytokine FAP-IL-2v Enhances Anti-Neuroblastoma Efficacy of the Anti-GD2 Antibody Dinutuximab Beta.
Siebert N, Leopold J, Zumpe M, Troschke-Meurer S, Biskupski S, Zikoridse A, Lode HN.
Siebert N, et al. Among authors: biskupski s.
Cancers (Basel). 2022 Oct 4;14(19):4842. doi: 10.3390/cancers14194842.
Cancers (Basel). 2022.
PMID: 36230765
Free PMC article.
Item in Clipboard
Cite
Cite